Eliapixant

N/A

Report date: 2026/02/11 20:01:36
NME

Base Information

Drug NameEliapixant
Drug Alias NameBAY-1817080
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP2X purinoceptor 3 antagonists
TargetsP2X purinoceptor 3
Therapy Area/IndicationsDiabetic peripheral neuropathyPainEndometriosis +[6
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[33
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active IndicationsN/A
Inactive IndicationsDiabetic peripheral neuropathyPainEndometriosis +[6

Other Information

ATC CodeN/A
Related LinksN/A